{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:42:59Z","timestamp":1791049379706,"version":"4.1.0"},"reference-count":137,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Heart involvement in eosinophilia represents a rare entity with substantial cardiac morbidity and mortality. This disorder is often overlooked and diagnosed in its advanced stages. In a subgroup of patients with eosinophilic heart disease, peripheral blood eosinophilia may not be present, and the biopsy of the affected organ or tissue is essential to establish the correct diagnosis. In this clinical consensus statement, an expert consensus group reviews the epidemiology, aetiology, diagnosis, and management of eosinophilic heart disease. The aim of the document is to increase awareness about the cardiac involvement associated with eosinophilia in order to diagnose the disease in early phases and prevent deleterious heart damage and adverse outcomes of affected individuals. The spectrum of physiological and immunological derangements requires a multidisciplinary approach for optimal management of affected individuals.<\/jats:p>","DOI":"10.1093\/ejhf\/xuag043","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T17:38:13Z","timestamp":1779385093000},"source":"Crossref","is-referenced-by-count":1,"title":["Current state of knowledge on the epidemiology, aetiology, diagnosis, and management of heart involvement in eosinophilia. A Clinical Consensus Statement of the ESC Working Group on Myocardial &amp; Pericardial Diseases"],"prefix":"10.1093","author":[{"given":"Petr","family":"Kuchynka","sequence":"first","affiliation":[{"name":"2nd Department of Medicine, Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague , 128 08, U Nemocnice 2, Prague 2 ,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-5600","authenticated-orcid":false,"given":"Antonio","family":"Brucato","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences, University of Milan , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5243-8985","authenticated-orcid":false,"given":"Carsten","family":"Tsch\u00f6pe","sequence":"additional","affiliation":[{"name":"German Heart Center at Charit\u00e9 (DHZC), Clinic for Cardiology, Angiology, and Intensive Medicine ,","place":["Germany"]},{"name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin ,","place":["Germany"]},{"name":"Berlin Institute of Health at Charit\u00e9 (BIH) ,","place":["Germany"]},{"name":"German Centre for Cardiovascular Research (DZHK), Partner Site Berlin ,","place":["Germany"]},{"name":"Center for Regenerative Therapies (BCRT) - Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3872-8964","authenticated-orcid":false,"given":"Matteo","family":"Cameli","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnologies, Division of Cardiology, University of Siena , Siena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Castelleti","sequence":"additional","affiliation":[{"name":"IRCCS, Istituto Auxologico Italiano, Department of Cardiology, San Luca Hospital, Cardiomyopathy Unit , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie T","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic , Jacksonville, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R","family":"Dweck","sequence":"additional","affiliation":[{"name":"British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh , Edinburgh ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5748-0725","authenticated-orcid":false,"given":"Andrea","family":"Frustaci","sequence":"additional","affiliation":[{"name":"Cellular and Molecular Cardiology Lab, IRCCS L. Spallanzani , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Heidecker","sequence":"additional","affiliation":[{"name":"German Heart Center at Charit\u00e9 (DHZC), Clinic for Cardiology, Angiology, and Intensive Medicine ,","place":["Germany"]},{"name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin ,","place":["Germany"]},{"name":"Berlin Institute of Health at Charit\u00e9 (BIH) ,","place":["Germany"]},{"name":"German Centre for Cardiovascular Research (DZHK), Partner Site Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0203-2498","authenticated-orcid":false,"given":"Karin","family":"Klingel","sequence":"additional","affiliation":[{"name":"Cardiopathology, Institute for Pathology and Neuropathology, University Hospital Tuebingen , Tuebingen ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Kuusisto","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland , Kuopio ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2802-9617","authenticated-orcid":false,"given":"George","family":"Lazaros","sequence":"additional","affiliation":[{"name":"1st Cardiology Department, Hippokration Hospital, National and Kapodistrian University of Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Merlo","sequence":"additional","affiliation":[{"name":"Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste , Trieste ,","place":["Italy"]},{"name":"Member of ERN-Guard HEART , Trieste ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonis","family":"Pantazis","sequence":"additional","affiliation":[{"name":"Royal Brompton and Harefield NHS Foundation Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen E","family":"Petersen","sequence":"additional","affiliation":[{"name":"William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University London , Charterhouse Square, London ,","place":["UK"]},{"name":"Barts Heart Centre, St Bartholomew's Hospital , , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelos G","family":"Rigopoulos","sequence":"additional","affiliation":[{"name":"Department of Adult Cardiology, Mitera General Hospital, Hygeia Group , Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsen D","family":"Risti\u0107","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Belgrade , Belgrade ,","place":["Serbia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frantisek","family":"Sedlak","sequence":"additional","affiliation":[{"name":"1st Department of Medicine, Department of Hematology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague , Prague ,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary N","family":"Sheppard","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Pathology, Cardiovascular and Genetics Research Institute, St Georges Medical School , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Imazio","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Udine , Udine ,","place":["Italy"]},{"name":"Cardiothoracic Department, University Hospital Santa Maria della Misericordia , Udine ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"2026052113380562800_xuag043-B1","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/ajh.27287","article-title":"World Health Organization and International Consensus classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management","volume":"99","author":"Shomali","year":"2024","journal-title":"Am J Hematol"},{"key":"2026052113380562800_xuag043-B2","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/ajh.23664","article-title":"World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management","volume":"89","author":"Gotlib","year":"2014","journal-title":"Am J Hematol"},{"key":"2026052113380562800_xuag043-B3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1136\/hrt.39.3.233","article-title":"Eosinophilia and heart disease","volume":"39","author":"Oakley","year":"1977","journal-title":"Br Heart J"},{"key":"2026052113380562800_xuag043-B4","doi-asserted-by":"publisher","first-page":"2829583","DOI":"10.1155\/2016\/2829583","article-title":"Current diagnostic and therapeutic aspects of eosinophilic myocarditis","volume":"2016","author":"Kuchynka","year":"2016","journal-title":"Biomed Res Int"},{"key":"2026052113380562800_xuag043-B5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jaci.2010.03.035","article-title":"Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence","volume":"126","author":"Crane","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"2026052113380562800_xuag043-B6","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.jaci.2009.09.022","article-title":"Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy","volume":"124","author":"Ogbogu","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"2026052113380562800_xuag043-B7","first-page":"1076","article-title":"Incidence of Churg\u2013Strauss syndrome in asthma drug users: a population-based perspective","volume":"32","author":"Harrold","year":"2005","journal-title":"J Rheumatol"},{"key":"2026052113380562800_xuag043-B8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/00015385.2017.1281546","article-title":"Hypereosinophilic cardiac disease","volume":"72","author":"Filippetti","year":"2017","journal-title":"Acta Cardiol"},{"key":"2026052113380562800_xuag043-B9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/08880010902773024","article-title":"Hypereosinophilic syndrome in childhood: clinical and molecular features of two cases","volume":"26","author":"Farruggia","year":"2009","journal-title":"Pediatr Hematol Oncol"},{"key":"2026052113380562800_xuag043-B10","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.anai.2023.02.022","article-title":"Hypereosinophilic syndrome in Europe: retrospective study of treatment patterns, clinical manifestations, and healthcare resource utilization","volume":"130","author":"Hwee","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026052113380562800_xuag043-B11","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1182\/blood.V83.10.2759.2759","article-title":"The idiopathic hypereosinophilic syndrome","volume":"83","author":"Weller","year":"1994","journal-title":"Blood"},{"key":"2026052113380562800_xuag043-B12","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1016\/j.jacc.2017.09.023","article-title":"Eosinophilic myocarditis: characteristics, treatment, and outcomes","volume":"70","author":"Brambatti","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026052113380562800_xuag043-B13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/bjh.14488","article-title":"British Committee for Standards in Haematology. Guideline for the investigation and management of eosinophilia","volume":"176","author":"Butt","year":"2017","journal-title":"Br J Haematol"},{"key":"2026052113380562800_xuag043-B14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ajh.26352","article-title":"World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Shomali","year":"2022","journal-title":"Am J Hematol"},{"key":"2026052113380562800_xuag043-B15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/all.15544","article-title":"Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes","volume":"78","author":"Valent","year":"2023","journal-title":"Allergy"},{"key":"2026052113380562800_xuag043-B16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00428-022-03402-8","article-title":"Updates on eosinophilic disorders","volume":"482","author":"Tzankov","year":"2023","journal-title":"Virchows Arch"},{"key":"2026052113380562800_xuag043-B17","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"2026052113380562800_xuag043-B18","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/ajh.26966","article-title":"The international consensus classification of eosinophilic disorders and systemic mastocytosis","volume":"98","author":"Wang","year":"2023","journal-title":"Am J Hematol"},{"key":"2026052113380562800_xuag043-B19","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1398-9995.1982.tb02339.x","article-title":"The hypereosinophilic syndrome: clinical features, laboratory findings, and treatment","volume":"37","author":"Spry","year":"1982","journal-title":"Allergy"},{"key":"2026052113380562800_xuag043-B20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/pgmj.59.689.147","article-title":"The cardiotoxicity of eosinophils","volume":"59","author":"Spry","year":"1983","journal-title":"Postgrad Med J"},{"key":"2026052113380562800_xuag043-B21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.7326\/0003-4819-97-1-78","article-title":"NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations","volume":"97","author":"Fauci","year":"1982","journal-title":"Ann Intern Med"},{"key":"2026052113380562800_xuag043-B22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0033-0620(85)90008-8","article-title":"Relation between eosinophilia and endomyocardial disease","volume":"27","author":"Olsen","year":"1985","journal-title":"Prog Cardiovasc Dis"},{"key":"2026052113380562800_xuag043-B23","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3390\/biomedicines12030656","article-title":"Eosinophilic myocarditis: from bench to bedside","volume":"12","author":"Piccirillo","year":"2024","journal-title":"Biomedicines"},{"key":"2026052113380562800_xuag043-B24","doi-asserted-by":"publisher","first-page":"100118","DOI":"10.1016\/j.jtauto.2021.100118","article-title":"Diagnosis and treatment of eosinophilic myocarditis","volume":"4","author":"Zhong","year":"2021","journal-title":"J Transl Autoimmun"},{"key":"2026052113380562800_xuag043-B25","first-page":"569","article-title":"\u201cL\u00f6ffler's syndrome\u201d","volume":"3","year":"1968","journal-title":"Br Med J"},{"key":"2026052113380562800_xuag043-B26","first-page":"817","article-title":"\u201cEndocarditis parietalis fibroplastica mit Bluteosinophilie. Ein eigenartiges Krankheitsbild\u201d. [Endocarditis parietal fibroplastica with eosinophilia. A strange disease]","volume":"66","author":"L\u00f6ffler","year":"1936","journal-title":"Schweizerische medizinische Wochenschrift (in German)"},{"key":"2026052113380562800_xuag043-B27","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/0140-6736(93)92211-B","article-title":"Endomyocardial fibrosis and eosinophilia","volume":"342","author":"Freers","year":"1993","journal-title":"Lancet"},{"key":"2026052113380562800_xuag043-B28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0001-706X(97)00125-3","article-title":"Helminth associated hypereosinophilia and tropical endomyocardial fibrosis in Nigeria","volume":"69","author":"Andy","year":"1998","journal-title":"Acta Trop"},{"key":"2026052113380562800_xuag043-B29","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0140-6736(87)90412-0","article-title":"Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial fibrosis","volume":"1","author":"Tai","year":"1987","journal-title":"Lancet"},{"key":"2026052113380562800_xuag043-B30","first-page":"277","article-title":"Allergic granulomatosis, allergic angiitis, and periarteritis nodosa","volume":"27","author":"Churg","year":"1951","journal-title":"Am J Pathol"},{"key":"2026052113380562800_xuag043-B31","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1038\/s41467-019-12515-9","article-title":"Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status","volume":"10","author":"Lyons","year":"2019","journal-title":"Nat Commun"},{"key":"2026052113380562800_xuag043-B32","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1378\/chest.96.3.674","article-title":"Persisting hypereosinophilia and myocardial activity in the fibrotic stage of endomyocardial disease","volume":"96","author":"Frustaci","year":"1989","journal-title":"Chest"},{"key":"2026052113380562800_xuag043-B33","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1136\/heartjnl-2015-307959","article-title":"Hypereosinophilic syndrome: cardiac diagnosis and management","volume":"102","author":"Mankad","year":"2016","journal-title":"Heart"},{"key":"2026052113380562800_xuag043-B34","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/j.jaip.2022.03.034","article-title":"Clinical profile and treatment in hypereosinophilic syndrome variants: a pragmatic review","volume":"10","author":"Requena","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026052113380562800_xuag043-B35","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/0002-9343(79)90227-4","article-title":"The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature","volume":"67","author":"Parrillo","year":"1979","journal-title":"Am J Med"},{"key":"2026052113380562800_xuag043-B36","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1056\/NEJM199011293232207","article-title":"Cardiac localization of eosinophil-granule major basic protein in acute necrotizing myocarditis","volume":"323","author":"deMello","year":"1990","journal-title":"N Engl J Med"},{"key":"2026052113380562800_xuag043-B37","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1136\/pmj.78.922.490-","article-title":"Unusual cardiac manifestation of hypereosinophilic syndrome","volume":"78","author":"Subhash","year":"2002","journal-title":"Postgrad Med J"},{"key":"2026052113380562800_xuag043-B38","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/s0003-4975(03)00689-1-","article-title":"Hypereosinophilic thrombus causing aortic stenosis and myocardial infarction","volume":"76","author":"D\u2019Souza","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"2026052113380562800_xuag043-B39","doi-asserted-by":"publisher","first-page":"188","DOI":"10.2459\/JCM.0b013e32831cf005","article-title":"Cardiac tamponade: a rare complication of idiopathic hypereosinophilic syndrome","volume":"10","author":"Fernandez","year":"2009","journal-title":"J Cardiovasc Med"},{"key":"2026052113380562800_xuag043-B40","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1001\/jamacardio.2024.1211","article-title":"A man in his 50\u2005s with dyspnea and eosinophilia","volume":"9","author":"Jakobs","year":"2024","journal-title":"JAMA Cardiol"},{"key":"2026052113380562800_xuag043-B41","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13023-023-02696-4","article-title":"French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes","volume":"18","author":"Groh","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"2026052113380562800_xuag043-B42","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/rheumatology\/keab514","article-title":"Revisiting characteristics, treatment and outcome of cardiomyopathy in eosinophilic granulomatosis with polyangiitis (formerly Churg\u2013Strauss)","volume":"61","author":"Sartorelli","year":"2022","journal-title":"Rheumatology"},{"key":"2026052113380562800_xuag043-B43","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1136\/heartjnl-2020-317202","article-title":"Hypereosinophilic syndrome: considerations for the cardiologist","volume":"108","author":"Bondue","year":"2022","journal-title":"Heart"},{"key":"2026052113380562800_xuag043-B44","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1136\/heartjnl-2023-323225","article-title":"Eosinophilic myocarditis: systematic review","volume":"110","author":"Techasatian","year":"2024","journal-title":"Heart"},{"key":"2026052113380562800_xuag043-B45","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.echo.2020.09.002","article-title":"Loeffler's endocarditis: an integrated multimodality approach","volume":"33","author":"Polito","year":"2020","journal-title":"J Am Soc Echocardiogr"},{"key":"2026052113380562800_xuag043-B46","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"2026052113380562800_xuag043-B47","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1007\/s10554-016-0917-x","article-title":"Very early stage left ventricular endocardial dysfunction of patients with hypereosinophilic syndrome","volume":"32","author":"Yamamoto","year":"2016","journal-title":"Int J Cardiovasc Imaging"},{"key":"2026052113380562800_xuag043-B48","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1093\/ehjci\/jeaa346","article-title":"Eosinophilic heart disease: diagnostic and prognostic assessment by cardiac magnetic resonance","volume":"22","author":"Antonopoulos","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026052113380562800_xuag043-B49","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2169\/internalmedicine.1303-18","article-title":"Usefulness of cardiac magnetic resonance in the diagnosis of Loffler endocarditis secondary to eosinophilic granulomatosis with polyangiitis","volume":"58","author":"Kurokawa","year":"2019","journal-title":"Intern Med"},{"key":"2026052113380562800_xuag043-B50","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12968-023-00979-0","article-title":"Cardiac magnetic resonance in histologically proven eosinophilic myocarditis","volume":"25","author":"Poyhonen","year":"2023","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026052113380562800_xuag043-B51","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1016\/j.ijcard.2007.01.019","article-title":"Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease","volume":"126","author":"Syed","year":"2008","journal-title":"Int J Cardiol"},{"key":"2026052113380562800_xuag043-B52","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jacc.2024.10.080","article-title":"2024 ACC expert consensus decision pathway on strategies and criteria for the diagnosis and management of myocarditis","volume":"85","author":"Drazner","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"2026052113380562800_xuag043-B53","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1532-429X-10-21","article-title":"Time course of eosinophilic myocarditis visualized by CMR","volume":"10","author":"Debl","year":"2008","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026052113380562800_xuag043-B54","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1007\/s00259-020-05066-5","article-title":"Procedural recommendations of cardiac PET\/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM","volume":"48","author":"Slart","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026052113380562800_xuag043-B55","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1440-1827.2007.02202.x","article-title":"Hypereosinophilic syndrome associated with occlusive coronary thrombosis and right ventricular thrombus","volume":"58","author":"Sato","year":"2008","journal-title":"Pathol Int"},{"key":"2026052113380562800_xuag043-B56","first-page":"25","article-title":"Control of hypereosinophilic syndrome-associated recalcitrant coronary artery spasm by combined treatment with prednisone, imatinib mesylate and hydroxyurea","volume":"11","author":"Butterfield","year":"2006","journal-title":"Exp Clin Cardiol"},{"key":"2026052113380562800_xuag043-B57","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/0002-9343(82)90853-1","article-title":"Spontaneous coronary artery dissection and eosinophilic inflammation: a cause and effect relationship?","volume":"72","author":"Robinowitz","year":"1982","journal-title":"Am J Med"},{"key":"2026052113380562800_xuag043-B58","first-page":"633","article-title":"Coronary artery dissections","volume":"2","author":"Virmani","year":"1984","journal-title":"Cardiol Clin"},{"key":"2026052113380562800_xuag043-B59","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3349\/ymj.2022.0279","article-title":"Giant coronary artery aneurysm with thrombosis complicated in a patient with idiopathic hypereosinophilic syndrome","volume":"64","author":"Kang","year":"2023","journal-title":"Yonsei Med J"},{"key":"2026052113380562800_xuag043-B60","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1017\/S1047951120004862","article-title":"Irreversible coronary aneurysm presenting as acute coronary syndrome in a child with hypereosinophilic syndrome: a case report","volume":"31","author":"Tahouri","year":"2021","journal-title":"Cardiol Young"},{"key":"2026052113380562800_xuag043-B61","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1161\/CIRCULATIONAHA.118.036124","article-title":"Coronary arteries and the cell count","volume":"139","author":"Divanji","year":"2019","journal-title":"Circulation"},{"key":"2026052113380562800_xuag043-B62","doi-asserted-by":"publisher","first-page":"e43-5","DOI":"10.1016\/j.ijcard.2007.08.136","article-title":"Hypereosinophilic syndrome associated with multiple coronary aneurysms","volume":"133","author":"Puri","year":"2009","journal-title":"Int J Cardiol"},{"key":"2026052113380562800_xuag043-B63","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00428-012-1351-7","article-title":"Eosinophilic coronary periarteritis (vasospastic angina and sudden death), a new type of coronary arteritis: report of seven autopsy cases and a review of the literature","volume":"462","author":"Kajihara","year":"2013","journal-title":"Virchows Arch"},{"key":"2026052113380562800_xuag043-B64","doi-asserted-by":"publisher","first-page":"586","DOI":"10.2169\/internalmedicine.44.586","article-title":"An autopsy case of isolated eosinophilic coronary periarteritis: a limited form of Churg\u2013Strauss syndrome or a new entity?","volume":"44","author":"Taira","year":"2005","journal-title":"Intern Med"},{"key":"2026052113380562800_xuag043-B65","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.acvd.2015.01.006","article-title":"Eosinophilic cardiac disease: molecular, clinical and imaging aspects","volume":"108","author":"Seguela","year":"2015","journal-title":"Arch Cardiovasc Dis"},{"key":"2026052113380562800_xuag043-B66","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/0002-8703(83)90491-x","article-title":"Endomyocardial fibrosis: report on the hemodynamic data in 29 patients and review of the results of surgery","volume":"105","author":"Cherian","year":"1983","journal-title":"Am Heart J"},{"key":"2026052113380562800_xuag043-B67","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1136\/hrt.38.6.541","article-title":"Clinical, haemodynamic, and angiographic findings in Loffler's eosinophilic endocarditis","volume":"38","author":"Bell","year":"1976","journal-title":"Br Heart J"},{"key":"2026052113380562800_xuag043-B68","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00392-019-01434-w","article-title":"Severe eosinophilic myocarditis associated with modafinil in a patient with normal peripheral eosinophil count","volume":"108","author":"B\u00e4uml","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"2026052113380562800_xuag043-B69","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1186\/s12872-022-02911-3","article-title":"Systemic thrombo-embolic events in a middle-aged male with Loeffler endocarditis without peripheral eosinophilia\u2014a case report","volume":"22","author":"Bohn\u00e9","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"2026052113380562800_xuag043-B70","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/ejhf.2190","article-title":"Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy","volume":"23","author":"Seferovi\u0107","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026052113380562800_xuag043-B71","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1093\/eurheartj\/ehaf192","article-title":"2025 ESC guidelines for the management of myocarditis and pericarditis","volume":"46","author":"Schulz-Menger","year":"2025","journal-title":"Eur Heart J"},{"key":"2026052113380562800_xuag043-B72","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1093\/eurheartj\/ehad707","article-title":"Fulminant myocarditis proven by early biopsy and outcomes","volume":"44","author":"Huang","year":"2023","journal-title":"Eur Heart J"},{"key":"2026052113380562800_xuag043-B73","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1016\/j.jacc.2017.09.022","article-title":"Eosinophilic myocarditis as a cause of acute cardiac syndromes: the importance of awareness","volume":"70","author":"Cooper","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026052113380562800_xuag043-B74","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/s0828-282x(06)70965-5","article-title":"Eosinophilic myocarditis: case series and review of literature","volume":"22","author":"Al Ali","year":"2006","journal-title":"Can J Cardiol"},{"key":"2026052113380562800_xuag043-B75","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00428-019-02615-8","article-title":"The spectrum of myocarditis: from pathology to the clinics","volume":"475","author":"Leone","year":"2019","journal-title":"Virchows Arch"},{"key":"2026052113380562800_xuag043-B76","doi-asserted-by":"publisher","first-page":"e012129","DOI":"10.1161\/CIRCEP.123.012129","article-title":"Myocarditis and sudden cardiac death in the community: clinical and pathological insights from a National Registry in the United Kingdom","volume":"16","author":"Bhatia","year":"2023","journal-title":"Circ. Arrhythmia Electrophysiol"},{"key":"2026052113380562800_xuag043-B77","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1056\/NEJM199805283382206","article-title":"Eosinophilia","volume":"338","author":"Rothenberg","year":"1998","journal-title":"N Engl J Med"},{"key":"2026052113380562800_xuag043-B78","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1046\/j.1440-1827.2001.01175.x","article-title":"A rat model of hypereosinophilic syndrome","volume":"51","author":"Sano","year":"2001","journal-title":"Pathol Int"},{"key":"2026052113380562800_xuag043-B79","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10875-021-01187-0","article-title":"First identified case of fatal fulminant necrotizing eosinophilic myocarditis following the initial dose of the Pfizer-BioNTech mRNA COVID-19 vaccine (BNT162b2, Comirnaty): an extremely rare idiosyncratic hypersensitivity reaction","volume":"42","author":"Ameratunga","year":"2022","journal-title":"J Clin Immunol"},{"key":"2026052113380562800_xuag043-B80","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.healun.2014.02.023","article-title":"Heart transplantation in patients with eosinophilic granulomatosis with polyangiitis (Churg\u2013Strauss syndrome)","volume":"33","author":"Groh","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"2026052113380562800_xuag043-B81","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1093\/eurheartj\/ehab364","article-title":"2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy","volume":"42","author":"Glikson","year":"2021","journal-title":"Eur Heart J"},{"key":"2026052113380562800_xuag043-B82","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"2026052113380562800_xuag043-B83","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"2026052113380562800_xuag043-B84","doi-asserted-by":"publisher","first-page":"e205","DOI":"10.1161\/CIR.0000000000001092","article-title":"Management of patients at risk for and with left ventricular thrombus: a scientific statement from the American Heart Association","volume":"146","author":"Levine","year":"2022","journal-title":"Circulation"},{"key":"2026052113380562800_xuag043-B85","doi-asserted-by":"publisher","first-page":"100915","DOI":"10.1016\/j.ijcha.2021.100915","article-title":"Literature reviews of stroke with hypereosinophilic syndrome","volume":"37","author":"Ono","year":"2021","journal-title":"Int J Cardiol Heart Vasc"},{"key":"2026052113380562800_xuag043-B86","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12959-024-00585-9","article-title":"Comparative effectiveness and safety of DOACs vs. VKAs in treatment of left ventricular thrombus\u2014a meta-analysis update","volume":"22","author":"Hu","year":"2024","journal-title":"Thromb J"},{"key":"2026052113380562800_xuag043-B87","doi-asserted-by":"publisher","first-page":"1018394","DOI":"10.3389\/fphar.2022.1018394","article-title":"Case report: application of non-VKA oral anticoagulants in patient of idiopathic hypereosinophilic syndrome with intracardiac thrombus","volume":"13","author":"Zou","year":"2022","journal-title":"Front Pharmacol"},{"key":"2026052113380562800_xuag043-B88","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/ajh.23120","article-title":"Treatment-refractory idiopathic hypereosinophilic syndrome: pitfalls and progress with use of novel drugs","volume":"87","author":"Bleeker","year":"2012","journal-title":"Am J Hematol"},{"key":"2026052113380562800_xuag043-B89","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.jaccas.2020.02.004","article-title":"A novel treatment for a rare cause of cardiogenic shock","volume":"2","author":"Chowdhury","year":"2020","journal-title":"JACC Case Rep"},{"key":"2026052113380562800_xuag043-B90","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/2045-7022-4-38","article-title":"High-dose intravenous immunoglobulin therapy for eosinophilic granulomatosis with polyangiitis","volume":"4","author":"Tsurikisawa","year":"2014","journal-title":"Clin Transl Allergy"},{"key":"2026052113380562800_xuag043-B91","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/art.41773","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2026052113380562800_xuag043-B92","doi-asserted-by":"publisher","first-page":"103338","DOI":"10.1016\/j.jaut.2024.103338","article-title":"Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors","volume":"149","author":"Sorin","year":"2024","journal-title":"J Autoimmun"},{"key":"2026052113380562800_xuag043-B93","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2174\/1573402114666180903164900","article-title":"Churg\u2013Strauss syndrome presenting as acute necrotizing eosinophilic myocarditis: concise review of the literature","volume":"15","author":"Chaudhry","year":"2019","journal-title":"Curr Hypertens Rev"},{"key":"2026052113380562800_xuag043-B94","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1182\/blood-2019-131687","article-title":"Efficacy and tolerance of interferon-\u03b1 in hypereosinophilic syndromes. a retrospective multicenter study on 29 patients","volume":"134","author":"De Malglaive","year":"2019","journal-title":"Blood"},{"key":"2026052113380562800_xuag043-B95","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1056\/NEJMoa070812","article-title":"Treatment of patients with the hypereosinophilic syndrome with mepolizumab","volume":"358","author":"Rothenberg","year":"2008","journal-title":"N Engl J Med"},{"key":"2026052113380562800_xuag043-B96","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.jaci.2009.01.069","article-title":"Treatment of FIP1L1\/PDGFRA-negative hypereosinophilic syndrome with alemtuzumab, an anti-CD52 antibody","volume":"123","author":"Wagner","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"2026052113380562800_xuag043-B97","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1182\/blood-2009-07-143552","article-title":"How I treat hypereosinophilic syndromes","volume":"114","author":"Klion","year":"2009","journal-title":"Blood"},{"key":"2026052113380562800_xuag043-B98","doi-asserted-by":"publisher","first-page":"106328","DOI":"10.1016\/j.jinf.2024.106328","article-title":"UK guidelines for the investigation and management of eosinophilia in returning travellers and migrants","volume":"90","author":"Thakker","year":"2025","journal-title":"J Infect"},{"key":"2026052113380562800_xuag043-B99","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1182\/blood-2002-10-3103","article-title":"Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders","volume":"101","author":"Pardanani","year":"2003","journal-title":"Blood"},{"key":"2026052113380562800_xuag043-B100","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3324\/haematol.11420","article-title":"The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study","volume":"92","author":"Baccarani","year":"2007","journal-title":"Haematologica"},{"key":"2026052113380562800_xuag043-B101","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1182\/blood-2021-148103","article-title":"Phase 2 study of pemigatinib (FIGHT-203; INCB054828) in patients with myeloid\/lymphoid neoplasms (MLNs) with Fibroblast Growth Factor Receptor 1 (FGFR1) rearrangement (MLN FGFR1)","volume":"138","author":"Gotlib","year":"2021","journal-title":"Blood"},{"key":"2026052113380562800_xuag043-B102","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/ajh.25825","article-title":"Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes","volume":"95","author":"Schwaab","year":"2020","journal-title":"Am J Hematol"},{"key":"2026052113380562800_xuag043-B103","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3390\/cancers16071383","article-title":"Clinical and therapeutic intervention of hypereosinophilia in the era of molecular diagnosis","volume":"16","author":"Nguyen","year":"2024","journal-title":"Cancers"},{"key":"2026052113380562800_xuag043-B104","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"; EGPA mepolizumab study team. Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N Engl J Med"},{"key":"2026052113380562800_xuag043-B105","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa2311155","article-title":"Benralizumab versus mepolizumab for eosinophilic granulomatosis with polyangiitis","volume":"390","author":"Wechsler","year":"2024","journal-title":"N Engl J Med"},{"key":"2026052113380562800_xuag043-B106","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/art.41943","article-title":"Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study","volume":"74","author":"Bettiol","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2026052113380562800_xuag043-B107","doi-asserted-by":"publisher","first-page":"1587158","DOI":"10.3389\/fimmu.2025.1587158","article-title":"Anti-IL5\/IL-5 receptor therapies for eosinophilic granulomatosis with polyangiitis: an updated systematic review","volume":"16","author":"Lazzeroni","year":"2025","journal-title":"Front Immunol"},{"key":"2026052113380562800_xuag043-B108","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026052113380562800_xuag043-B109","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"key":"2026052113380562800_xuag043-B110","doi-asserted-by":"publisher","first-page":"4400","DOI":"10.1111\/jocs.15927","article-title":"Recurrent prosthetic valve dysfunction in a patient with idiopathic hypereosinophilic syndrome: a case report and literature review","volume":"36","author":"Wei","year":"2021","journal-title":"J Card Surg"},{"key":"2026052113380562800_xuag043-B111","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1093\/ehjci\/jey032","article-title":"Multimodality imaging in endomyocardial fibrosis associated with Hodgkin lymphoma","volume":"19","author":"Kuchynka","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026052113380562800_xuag043-B112","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S1010-7940(99)00027-5","article-title":"Surgery for endomyocardial fibrosis revisited","volume":"15","author":"Moraes","year":"1999","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026052113380562800_xuag043-B113","doi-asserted-by":"publisher","first-page":"101995","DOI":"10.1016\/j.cpcardiol.2023.101995","article-title":"Endomyocardiofibrosis in the Americas Collaborative Study: the EMF-SIAC Registry","volume":"48","author":"Scatularo","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"2026052113380562800_xuag043-B114","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1097\/01.ccm.0000114818.58877.06","article-title":"Eosinophilic myocarditis in patients awaiting heart transplantation","volume":"32","author":"Takkenberg","year":"2004","journal-title":"Crit Care Med"},{"key":"2026052113380562800_xuag043-B115","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1161\/CIRCULATIONAHA.117.026386","article-title":"Survival and left ventricular function changes in fulminant versus nonfulminant acute myocarditis","volume":"136","author":"Ammirati","year":"2017","journal-title":"Circulation"},{"key":"2026052113380562800_xuag043-B116","doi-asserted-by":"publisher","first-page":"535","DOI":"10.23736\/S2724-5683.23.06287-7","article-title":"Eosinophilic myocarditis: comprehensive update on pathophysiology, diagnosis, prognosis and management","volume":"71","author":"Collini","year":"2023","journal-title":"Minerva Cardiol Angiol"},{"key":"2026052113380562800_xuag043-B117","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1536\/ihj.54.146","article-title":"Characteristics of patients with advanced heart failure having eosinophilic infiltration of the myocardium in the recent era","volume":"54","author":"Yoshizawa","year":"2013","journal-title":"Int Heart J"},{"key":"2026052113380562800_xuag043-B118","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1161\/CIR.0000000000000745","article-title":"American Heart Association \u201crecognition and initial management of fulminant myocarditis\u201d","volume":"141","author":"Kociol","year":"2020","journal-title":"Circulation"},{"key":"2026052113380562800_xuag043-B119","doi-asserted-by":"publisher","first-page":"103037","DOI":"10.1016\/j.autrev.2022.103037","article-title":"Myocarditis in systemic immune-mediated diseases: prevalence, characteristics and prognosis. A systematic review","volume":"21","author":"Cheng","year":"2022","journal-title":"Autoimmun Rev"},{"key":"2026052113380562800_xuag043-B120"},{"key":"2026052113380562800_xuag043-B121","doi-asserted-by":"publisher","first-page":"7214","DOI":"10.3390\/jcm12237214","article-title":"Biomarkers in acute myocarditis and chronic inflammatory cardiomyopathy: an updated review of the literature","volume":"12","author":"Crisci","year":"2023","journal-title":"J Clin Med"},{"key":"2026052113380562800_xuag043-B122","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/s0167-5273(02)00074-8","article-title":"Serum levels of eosinophil cationic protein in patients with eosinophilic myocarditis","volume":"84","author":"Arima","year":"2002","journal-title":"Int J Cardiol"},{"key":"2026052113380562800_xuag043-B123","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1007\/s10554-023-02927-6","article-title":"Cardiovascular magnetic resonance (CMR) and positron emission tomography (PET) imaging in the diagnosis and follow-up of patients with acute myocarditis and chronic inflammatory cardiomyopathy: a review paper with practical recommendations on behalf of the European Society of Cardiovascular Radiology (ESCR)","volume":"39","author":"Caobelli","year":"2023","journal-title":"Int J Cardiovasc Imaging"},{"key":"2026052113380562800_xuag043-B124","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/rheumatology\/kes155","article-title":"Churg\u2013Strauss syndrome cardiac involvement evaluated by cardiac magnetic resonance imaging and positron-emission tomography: a prospective study on 20 patients","volume":"52","author":"Marmursztejn","year":"2013","journal-title":"Rheumatology"},{"key":"2026052113380562800_xuag043-B125","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/08465371221119713","article-title":"Cardiac imaging in myocarditis: current evidence and future directions","volume":"74","author":"Urzua Fresno","year":"2023","journal-title":"Can Assoc Radiol J"},{"key":"2026052113380562800_xuag043-B126","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.jcmg.2021.11.017","article-title":"Multiparametric cardiovascular magnetic resonance approach in diagnosing, monitoring, and prognostication of myocarditis","volume":"15","author":"Eichhorn","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026052113380562800_xuag043-B127","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.jcmg.2020.04.025","article-title":"Feature tracking myocardial strain incrementally improves prognostication in myocarditis beyond traditional CMR imaging features","volume":"13","author":"Fischer","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026052113380562800_xuag043-B128","doi-asserted-by":"publisher","first-page":"e007405","DOI":"10.1161\/CIRCHEARTFAILURE.120.007405","article-title":"Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document","volume":"13","author":"Ammirati","year":"2020","journal-title":"Circ Heart Fail"},{"key":"2026052113380562800_xuag043-B129","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1093\/eurheartj\/ehx321","article-title":"Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease","volume":"38","author":"Caforio","year":"2017","journal-title":"Eur Heart J"},{"key":"2026052113380562800_xuag043-B130"},{"key":"2026052113380562800_xuag043-B131"},{"key":"2026052113380562800_xuag043-B132"},{"key":"2026052113380562800_xuag043-B133"},{"key":"2026052113380562800_xuag043-B134"},{"key":"2026052113380562800_xuag043-B135"},{"key":"2026052113380562800_xuag043-B136"},{"key":"2026052113380562800_xuag043-B137"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjhf\/advance-article-pdf\/doi\/10.1093\/ejhf\/xuag043\/68360712\/xuag043.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/advance-article-pdf\/doi\/10.1093\/ejhf\/xuag043\/68360712\/xuag043.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T17:38:16Z","timestamp":1779385096000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/advance-article\/doi\/10.1093\/ejhf\/xuag043\/8690085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":137,"URL":"https:\/\/doi.org\/10.1093\/ejhf\/xuag043","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"article-number":"xuag043"}}